Cargando…

Reducing Delusional Conviction through a Cognitive-Based Group Training Game: A Multicentre Randomized Controlled Trial

OBJECTIVE: “Michael’s game” (MG) is a card game targeting the ability to generate alternative hypotheses to explain a given experience. The main objective was to evaluate the effect of MG on delusional conviction as measured by the primary study outcome: the change in scores on the conviction subsca...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazaal, Yasser, Chatton, Anne, Dieben, Karen, Huguelet, Philippe, Boucherie, Maria, Monney, Gregoire, Lecardeur, Laurent, Salamin, Virginie, Bretel, Fethi, Azoulay, Silke, Pesenti, Elodie, Krychowski, Raoul, Costa Prata, Andreia, Bartolomei, Javier, Brazo, Perrine, Traian, Alexei, Charpeaud, Thomas, Murys, Elodie, Poupart, Florent, Rouvière, Serge, Zullino, Daniele, Parabiaghi, Alberto, Saoud, Mohamed, Favrod, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412136/
https://www.ncbi.nlm.nih.gov/pubmed/25972817
http://dx.doi.org/10.3389/fpsyt.2015.00066
Descripción
Sumario:OBJECTIVE: “Michael’s game” (MG) is a card game targeting the ability to generate alternative hypotheses to explain a given experience. The main objective was to evaluate the effect of MG on delusional conviction as measured by the primary study outcome: the change in scores on the conviction subscale of the Peters delusions inventory (PDI-21). Other variables of interest were the change in scores on the distress and preoccupation subscales of the PDI-21, the brief psychiatric rating scale, the Beck cognitive insight scale, and belief flexibility assessed with the Maudsley assessment of delusions schedule (MADS). METHODS: We performed a parallel, assessor-blinded, randomized controlled superiority trial comparing treatment as usual plus participation in MG with treatment as usual plus being on a waiting list (TAU) in a sample of adult outpatients with psychotic disorders and persistent positive psychotic symptoms at inclusion. RESULTS: The 172 participants were randomized, with 86 included in each study arm. Assessments were performed at inclusion (T1: baseline), at 3 months (T2: post-treatment), and at 6 months after the second assessment (T3: follow-up). At T2, a positive treatment effect was observed on the primary outcome, the PDI-21 conviction subscale (p = 0.005). At T3, a sustained effect was observed for the conviction subscale (p = 0.002). Further effects were also observed at T3 on the PDI-21 distress (p = 0.002) and preoccupation subscales (p = 0.001), as well as on one of the MADS measures of belief flexibility (“anything against the belief”) (p = 0.001). CONCLUSION: The study demonstrated some significant beneficial effect of MG.